Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,252 | 30,109 | 27,940 | 48,642 | 35,277 |
| Marketable Securities | 210,974 | 214,386 | 243,295 | 240,596 | 268,339 |
| Receivables | N/A | N/A | 1,196 | 3,617 | 1,205 |
| Inventories | N/A | N/A | 14,465 | 16,238 | 16,101 |
| Other current assets | 6,066 | 41,986 | 8,292 | 10,743 | 9,779 |
| TOTAL | $261,292 | $286,481 | $295,188 | $319,836 | $330,701 |
| Non-Current Assets | |||||
| PPE Net | 3,411 | 3,603 | 15,187 | 17,475 | 18,856 |
| Investments And Advances | 26,087 | 4,537 | 19,405 | 36,778 | 25,825 |
| Other Non-Current Assets | 13,060 | 13,345 | 13,554 | 21,923 | 22,651 |
| TOTAL | $42,558 | $21,485 | $48,146 | $76,176 | $67,332 |
| Total Assets | $303,850 | $307,966 | $343,334 | $396,012 | $398,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,560 | 8,577 | 6,475 | 8,757 | 9,848 |
| Accrued Expenses | 29,972 | 32,377 | 29,514 | 24,281 | 22,162 |
| Other current liabilities | N/A | 5,125 | N/A | N/A | N/A |
| TOTAL | $61,400 | $67,583 | $57,326 | $52,406 | $51,269 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 181,713 | 191,499 | 206,320 | 216,901 | 215,777 |
| TOTAL | $181,713 | $191,499 | $206,320 | $216,901 | $215,777 |
| Total Liabilities | $243,113 | $259,082 | $263,646 | $269,307 | $267,046 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,413 | 12,303 | 12,278 | 12,248 | 12,247 |
| Common Shares | 1 | 19 | 19 | 19 | 19 |
| Retained earnings | -3,596,210 | -3,603,471 | -3,566,414 | -3,514,051 | -3,477,249 |
| Other shareholders' equity | 61 | 355 | -494 | -403 | 80 |
| TOTAL | $60,737 | $48,884 | $79,688 | $126,705 | $130,987 |
| Total Liabilities And Equity | $303,850 | $307,966 | $343,334 | $396,012 | $398,033 |